Subchapter 11-A: GENETICALLY ENGINEERED PLANTS AND SEEDS HEADING: PL 2001, C. 330, §1 (NEW)
§1055. Restrictions on the production of pharmaceutical or industrial crops
(CONTAINS TEXT WITH VARYING EFFECTIVE DATES)
(WHOLE SECTION TEXT EFFECTIVE UNTIL 7/1/12)
(WHOLE SECTION TEXT REPEALED 7/1/12 by T. 7, §1055, sub-§4)
1. Prohibition on open-air production. Except as provided in subsection 2, a person may not grow any pharmaceutical or industrial crop that requires a field test permit from the United States Department of Agriculture, Animal and Plant Health Inspection Service under 7 Code of Federal Regulations, Part 340.
[ 2009, c. 388, §2 (NEW) .]
2. Containment required. A person may grow a pharmaceutical or industrial crop as long as:
A. The production is done in a state or federally licensed medical research institution or laboratory; [2009, c. 388, §2 (NEW).]
B. All production activities are conducted under secure, enclosed indoor laboratory conditions to prevent the release of genetically engineered material and cross pollination with nongenetically engineered crops; and [2009, c. 388, §2 (NEW).]
C. A permit required by the United States Department of Agriculture for production of the pharmaceutical or industrial crop has been received and is valid. [2009, c. 388, §2 (NEW).]
[ 2009, c. 388, §2 (NEW) .]
3. Monitoring of federal regulations. The commissioner shall monitor federal regulation of pharmaceutical or industrial crops. The commissioner shall report to the joint standing committee of the Legislature having jurisdiction over agriculture matters any change in federal regulation that allows the production of pharmaceutical and industrial crops without a permit.
Subchapter 11-A: GENETICALLY ENGINEERED PLANTS AND SEEDS HEADING: PL 2001, C. 330, §1 (NEW)
§1055. Restrictions on the production of pharmaceutical or industrial crops
(CONTAINS TEXT WITH VARYING EFFECTIVE DATES)
(WHOLE SECTION TEXT EFFECTIVE UNTIL 7/1/12)
(WHOLE SECTION TEXT REPEALED 7/1/12 by T. 7, §1055, sub-§4)
1. Prohibition on open-air production. Except as provided in subsection 2, a person may not grow any pharmaceutical or industrial crop that requires a field test permit from the United States Department of Agriculture, Animal and Plant Health Inspection Service under 7 Code of Federal Regulations, Part 340.
[ 2009, c. 388, §2 (NEW) .]
2. Containment required. A person may grow a pharmaceutical or industrial crop as long as:
A. The production is done in a state or federally licensed medical research institution or laboratory; [2009, c. 388, §2 (NEW).]
B. All production activities are conducted under secure, enclosed indoor laboratory conditions to prevent the release of genetically engineered material and cross pollination with nongenetically engineered crops; and [2009, c. 388, §2 (NEW).]
C. A permit required by the United States Department of Agriculture for production of the pharmaceutical or industrial crop has been received and is valid. [2009, c. 388, §2 (NEW).]
[ 2009, c. 388, §2 (NEW) .]
3. Monitoring of federal regulations. The commissioner shall monitor federal regulation of pharmaceutical or industrial crops. The commissioner shall report to the joint standing committee of the Legislature having jurisdiction over agriculture matters any change in federal regulation that allows the production of pharmaceutical and industrial crops without a permit.
Subchapter 11-A: GENETICALLY ENGINEERED PLANTS AND SEEDS HEADING: PL 2001, C. 330, §1 (NEW)
§1055. Restrictions on the production of pharmaceutical or industrial crops
(CONTAINS TEXT WITH VARYING EFFECTIVE DATES)
(WHOLE SECTION TEXT EFFECTIVE UNTIL 7/1/12)
(WHOLE SECTION TEXT REPEALED 7/1/12 by T. 7, §1055, sub-§4)
1. Prohibition on open-air production. Except as provided in subsection 2, a person may not grow any pharmaceutical or industrial crop that requires a field test permit from the United States Department of Agriculture, Animal and Plant Health Inspection Service under 7 Code of Federal Regulations, Part 340.
[ 2009, c. 388, §2 (NEW) .]
2. Containment required. A person may grow a pharmaceutical or industrial crop as long as:
A. The production is done in a state or federally licensed medical research institution or laboratory; [2009, c. 388, §2 (NEW).]
B. All production activities are conducted under secure, enclosed indoor laboratory conditions to prevent the release of genetically engineered material and cross pollination with nongenetically engineered crops; and [2009, c. 388, §2 (NEW).]
C. A permit required by the United States Department of Agriculture for production of the pharmaceutical or industrial crop has been received and is valid. [2009, c. 388, §2 (NEW).]
[ 2009, c. 388, §2 (NEW) .]
3. Monitoring of federal regulations. The commissioner shall monitor federal regulation of pharmaceutical or industrial crops. The commissioner shall report to the joint standing committee of the Legislature having jurisdiction over agriculture matters any change in federal regulation that allows the production of pharmaceutical and industrial crops without a permit.
